Dec. 15, 2022
by Basem Goueli MD/PhD/MBA
Biopharma insight
In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …
Aug. 8, 2022
by Natalia Honchar
Biopharma insight
Auron Therapeutics, a biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular plasticity for treating cancer, just …
Aug. 5, 2022
by Natalia Honchar
Biopharma insight
Owkin, a biotech startup that uses artificial intelligence (AI) for precision cancer therapy development is partnering with scientists from the …
Aug. 3, 2022
by Basem Goueli MD/PhD/MBA
Biopharma insight
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
July 21, 2022
by Basem Goueli, M.D., Ph.D., MBA
Biopharma insight
In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our …
July 14, 2022
by Basem Goueli MD/PhD/MBA
Biopharma insight
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
June 23, 2022
by Basem Goueli MD/PhD/MBA
Biopharma insight
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve …
May 5, 2022
by Basem Goueli, M.D., Ph.D., MBA
Biopharma insight
We are witnessing a revolution in cancer therapeutics that is truly bewildering. The number of novel drugs with unique mechanisms …
April 21, 2022
by Basem Goueli, MD, PhD, MBA
Biopharma insight
I always think of the Jeff Goldblum quote in Jurassic Park where he says "life finds a way" when I …
Feb. 9, 2020
by Irina Bilous
Biopharma insight
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
Feb. 6, 2020
by Caroline Green
Biopharma insight
In a recent study published in Nature Communications, scientists from Cornell University made new findings in common and fatal gastric …